Capability, opportunity and motivation for shared decision‐making about valproate as an antiseizure medication treatment for epilepsy in women with pregnancy potential: A qualitative study of patient perspectives
Comprehensive SDM when valproate is considered clinically appropriate could support informed, patient-centred decision-making. Equipping clinicians to navigate multifaceted risk/benefit discussions and empowering patients with clear, tailored information can help ensure treatment decisions align with reproductive goals. This study highlights the need to embed SDM in valproate prescribing consultations and throughout treatment duration.
Authors
- Christine McKnight (ORCID: https://orcid.org/0000-0001-5007-9296)
- Léonie James
- Denitza Williams
- Andrew Evans (ORCID: https://orcid.org/0000-0001-9486-283X)
- William Owen Pickrell (ORCID: https://orcid.org/0000-0003-4396-5657)
- Delyth James (ORCID: https://orcid.org/0000-0001-7434-7064)
- Rhiannon Phillips (ORCID: https://orcid.org/0000-0002-4256-4598)
- Sarah Brown (ORCID: https://orcid.org/0000-0001-7699-4417)
- Sarah Louise Griffiths (ORCID: https://orcid.org/0009-0004-0236-7268)
Institutions
- Swansea Bay University Health Board (GB)
- Cardiff and Vale University Health Board (GB)
- University of Liverpool (GB)
- Welsh Government (GB)
- Swansea University (GB)
- Cardiff University (GB)
- Cardiff Metropolitan University (GB)
Publication Details
- Journal
- British Journal of Health Psychology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1111/bjhp.70045
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00